Back to Search
DALE CUNNINGHAM, MD
MD
Physical Medicine & Rehabilitation Physician
NPI: 1821098690IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
19723(TN)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Class of 1986
Research & Publications (20)
The morphometric relationship of Upper Cave 101 and 103 to modern Homo sapiens.
PMID 12890442·J Hum Evol·2003
4-observational
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.
PMID 19406901·Ann Oncol·2009
3-trial
Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry.
PMID 19573860·Am J Ophthalmol·2009
4-observational
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
PMID 19497945·Ann Oncol·2009
8-other
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.
PMID 19474114·Ann Oncol·2009
1-meta
Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.
PMID 19470917·J Clin Oncol·2009
4-observational
Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint.
PMID 19463175·Microb Cell Fact·2009
8-other
Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
PMID 19454457·Ann Oncol·2009
6-review
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.
PMID 19451425·J Clin Oncol·2009
3-trial
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
PMID 19450285·BMC Cancer·2009
3-trial
A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma.
PMID 19436301·Br J Cancer·2009
3-trial
Developmental expression pattern of the cholesterogenic enzyme NSDHL and negative selection of NSDHL-deficient cells in the heterozygous Bpa(1H)/+ mouse.
PMID 19631568·Mol Genet Metab·2009
7-preclinical
Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection.
PMID 19404073·Dis Colon Rectum·2009
4-observational
Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.
PMID 19398575·J Clin Oncol·2009
4-observational
Compartment-specific regulation of plasma membrane calcium ATPase type 2 in the chick auditory brainstem.
PMID 19365819·J Comp Neurol·2009
7-preclinical
Optimising treatment regimens for the management of advanced gastric cancer.
PMID 19321659·Ann Oncol·2009
8-other
Complex training in professional rugby players: influence of recovery time on upper-body power output.
PMID 19675483·J Strength Cond Res·2009
8-other
Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?
PMID 19643598·Eur J Cancer·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 651 DUNLOP LN
CLARKSVILLE, TN 37040 - Phone
- (877) 749-7428
Quick Facts
- NPI
- 1821098690
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile